A patient with a history of hypertension, diabetes, and hyperlipidemia has been diagnosed with an inferior wall myocardial infarction and is being prepared for a percutaneous coronary intervention (PCI). Which nursing intervention should the nurse prioritize pre-procedure to reduce the risk of contrast-induced nephropathy?

B) Ensure adequate hydration with IV fluids

A) Administer a statin medication as prescribed

B) Ensure adequate hydration with IV fluids

C) Educate the patient about smoking cessation

D) Monitor for signs of reperfusion arrhythmias

A patient with a diagnosed inferior wall myocardial infarction has been transferred to the cardiac catheterization lab for PCI. Which nursing intervention is most important to prevent complications associated with this patient's underlying conditions during the procedure?

A) Administering a bolus of normal saline prior to contrast administration

B) Placing the patient in Trendelenburg position to improve venous return

C) Encouraging the patient to perform deep breathing exercises

D) Applying warm blankets to maintain body temperature

A patient recovering from a percutaneous coronary intervention (PCI) exhibits a sudden increase in heart rate, irregular rhythm with frequent PVCs, mild chest discomfort, and a slight drop in blood pressure. Which nursing intervention is the priority to prevent further deterioration of the patient's condition?

B) Administer the prescribed low-dose beta-blocker immediately.

A) Increase the patient's oxygen to 4 L/min via nasal cannula.

B) Administer the prescribed low-dose beta-blocker immediately.

C) Reassess the patient's pain level and administer analgesics as needed.

D) Prepare the patient for an immediate repeat echocardiogram.

A patient is showing signs of potential arrhythmia with a sudden increase in heart rate, irregular rhythm, and frequent PVCs after a successful PCI. The nurse notes a drop in blood pressure and mild chest discomfort. What should be the nurse's priority intervention in this situation?

C) Notify the healthcare provider of the patient's changes and prepare to administer prescribed beta-blockers.

A) Administer supplemental oxygen to improve oxygen saturation.

B) Prepare for immediate cardioversion to address the irregular rhythm.

C) Notify the healthcare provider of the patient's changes and prepare to administer prescribed beta-blockers.

D) Increase the patient's fluid intake to address the low blood pressure.

A patient experiencing acute decompensated heart failure following myocardial infarction presents with pulmonary congestion and low blood pressure. The medical team has administered intravenous furosemide and adjusted the patient's positioning. Which additional nursing intervention should be prioritized to support the patient's hemodynamic status and prevent further complications?

B) Monitor urine output and renal function closely

A) Encourage increased oral fluid intake to counteract hypotension

B) Monitor urine output and renal function closely

C) Administer a high-sodium diet to improve blood pressure

D) Place the patient in a supine position to increase venous return

A patient with acute decompensated heart failure presents with increasing respiratory distress and hypotension after the initiation of a low-dose beta-blocker. Following administration of IV furosemide, the patient's blood pressure remains low. Which nursing intervention is most appropriate to enhance cardiac output without worsening hypotension?

D) Initiate a norepinephrine infusion to support blood pressure

A) Increase the beta-blocker dosage to manage arrhythmias

B) Administer a fluid bolus to increase blood pressure

C) Adjust the patient's position to high Fowler's to ease breathing

D) Initiate a norepinephrine infusion to support blood pressure

A patient with heart failure post-myocardial infarction is being treated with diuretics and a low-dose inotropic agent. The patient's latest laboratory results show a serum potassium level of 5.4 mEq/L and a creatinine level of 2.0 mg/dL. What is the most appropriate nursing intervention to prioritize at this time?

C) Collaborate with the healthcare team to adjust the diuretic dosage

A) Administer potassium supplements to prevent hypokalemia

B) Initiate a high-sodium diet to manage electrolyte imbalance

C) Collaborate with the healthcare team to adjust the diuretic dosage

D) Increase the dosage of the inotropic agent to improve cardiac output

A patient with heart failure post-myocardial infarction is being treated with diuretics and inotropic agents. The patient has an elevated serum potassium level of 5.4 mEq/L and a creatinine level of 2.0 mg/dL. What is the most appropriate nursing intervention to prioritize at this time?

B) Monitor the patient's cardiac rhythm continuously

A) Administer sodium polystyrene sulfonate to lower potassium levels

B) Monitor the patient's cardiac rhythm continuously

C) Increase the dose of diuretics to enhance fluid removal

D) Initiate renal replacement therapy immediately

A patient with worsening renal function and hyperkalemia is being treated with calcium gluconate, insulin with glucose, and a potassium-wasting diuretic. Which of the following nursing interventions is the most critical to implement at this time?

B) Check blood glucose levels hourly.

A) Monitor the patient's urine output closely.

B) Check blood glucose levels hourly.

C) Assess the patient’s neurological status every 2 hours.

D) Prepare the patient for immediate dialysis.

A patient receiving an inotropic agent exhibits increasing restlessness, confusion, and a rise in serum potassium to 5.8 mEq/L. The healthcare team is considering interventions to manage the hyperkalemia and support renal function. Which nursing intervention is the most appropriate to prioritize at this time?

C) Administer calcium gluconate intravenously

A) Administer sodium polystyrene sulfonate orally

B) Prepare the patient for renal replacement therapy

C) Administer calcium gluconate intravenously

D) Encourage oral fluid intake to promote renal excretion of potassium

Heart attacks - Nursing Case Study

Pathophysiology

• Primary mechanism: Atherosclerosis - Plaque builds up in coronary arteries, narrowing them and reducing blood flow to the heart muscle. This buildup can rupture, leading to the formation of a blood clot that obstructs the artery completely.

• Secondary mechanism: Thrombosis - When a plaque ruptures, the body attempts to repair the injury, leading to thrombus (blood clot) formation. This clot can rapidly grow and occlude the coronary artery, blocking oxygen and nutrients to the heart muscle.

• Key complication: Myocardial Ischemia and Infarction - Reduced blood flow results in ischemia, a condition where the heart muscle is deprived of oxygen. If blood flow is not restored quickly, myocardial infarction (heart attack) occurs, causing irreversible damage to the heart tissue, impairing its function and potentially leading to heart failure or arrhythmias.

Patient Profile

Demographics:

68-year-old male, retired construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Hyperlipidemia

• Current medications: Metformin, Lisinopril, Atorvastatin, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Chest pain radiating to the left arm

• Key symptoms: Shortness of breath, nausea, diaphoresis (sweating), dizziness

• Vital signs: Blood pressure 160/95 mmHg, heart rate 110 bpm, respiratory rate 24 breaths per minute, temperature 37.8°C, oxygen saturation 92% on room air

Section 1

Initial Assessment Findings:

Upon arrival at the emergency department, the initial assessment of the patient reveals significant findings consistent with acute coronary syndrome. The patient appears diaphoretic and pale, with an anxious expression and labored breathing. Auscultation of the heart reveals an S4 gallop, a finding that suggests decreased ventricular compliance and increased left ventricular filling pressure, often associated with ischemia. Lung sounds are clear bilaterally, but the patient exhibits mild use of accessory muscles, indicating respiratory distress. Peripheral pulses are present but weak, and capillary refill is delayed at 3-4 seconds, suggesting potential circulatory compromise.

An electrocardiogram (ECG) is performed immediately, showing ST-segment elevation in the inferior leads, which is indicative of an inferior wall myocardial infarction. Laboratory tests are ordered, including cardiac biomarkers such as troponin I, which later returns elevated, confirming myocardial damage. A chest X-ray is done to rule out other causes of chest pain, and it appears unremarkable, with no evidence of pneumonia or pneumothorax. The combination of clinical presentation, ECG changes, and elevated biomarkers leads to the diagnosis of an acute myocardial infarction, necessitating urgent intervention to restore coronary blood flow.

The patient is quickly moved to the cardiac catheterization lab for a percutaneous coronary intervention (PCI). Given his history of hypertension, diabetes, and hyperlipidemia, the risk for further complications, such as arrhythmias or heart failure, remains significant. This necessitates close monitoring of vital signs and continuous ECG during and after the procedure. The healthcare team must remain vigilant for signs of reperfusion injury or contrast-induced nephropathy, especially considering the patient's diabetes, which predisposes him to renal complications. This careful assessment and rapid intervention highlight the importance of timely and accurate clinical reasoning in managing acute cardiac events.

Section 2

As the patient is transferred from the cardiac catheterization lab following a successful PCI, there is an initial improvement in his clinical status. His previously labored breathing eases, and his skin color improves slightly, suggesting a positive response to the restoration of blood flow. However, the medical team remains cautious, closely monitoring for potential complications associated with post-infarction recovery. Over the next several hours, the patient begins to exhibit signs that warrant further investigation.

The nurse observes a sudden increase in the patient’s heart rate, now at 110 beats per minute, coupled with a new onset of irregular rhythm detected on the continuous ECG monitoring. The telemetry reveals frequent premature ventricular contractions (PVCs), raising concerns about the potential for more significant arrhythmias. Concurrently, the patient reports a feeling of increased fatigue and mild chest discomfort, which prompts the team to reassess his condition urgently. Vital signs indicate a slight drop in blood pressure to 95/60 mmHg, and oxygen saturation remains stable at 94% on room air.

In light of these changes, the team re-evaluates the patient's laboratory results and finds a further rise in troponin levels, reflecting ongoing myocardial stress. Additionally, a follow-up echocardiogram reveals mild left ventricular dysfunction, reinforcing the need for vigilant management of heart failure symptoms. The patient is started on a low-dose beta-blocker to manage the arrhythmias and improve cardiac output, while diuretics are considered to prevent fluid overload. This evolving clinical picture demands careful adjustment of the treatment plan, highlighting the need for continuous reassessment and dynamic decision-making to prevent deterioration and ensure optimal recovery.

Section 3

As the medical team continues to monitor the patient closely, they encounter new complications that necessitate further clinical intervention. Approximately two hours after the initiation of the low-dose beta-blocker, the patient's condition evolves. Despite the initial stabilization of his arrhythmias, the patient now presents with increasing respiratory distress. His respiratory rate escalates to 28 breaths per minute, and auscultation of the lungs reveals bilateral crackles, suggesting pulmonary congestion. This change prompts the medical team to suspect acute decompensated heart failure, a common complication following myocardial infarction and percutaneous coronary intervention.

In response to these new findings, the patient's diuretic therapy is promptly initiated with intravenous furosemide to alleviate the fluid overload and reduce the burden on the failing left ventricle. The team also adjusts the patient's positioning to semi-Fowler’s to enhance lung expansion and ease breathing. Despite these measures, his blood pressure remains low at 92/58 mmHg, raising concerns about maintaining adequate organ perfusion without further compromising cardiac output. The need for careful titration of medications becomes evident, as the team must balance the management of heart failure symptoms with the risk of exacerbating hypotension.

To guide further treatment decisions, additional laboratory tests are conducted, which reveal a slight reduction in renal function, evidenced by a creatinine level that has risen to 1.8 mg/dL. This finding underscores the importance of cautious fluid management and the potential need for renal protective strategies. The patient's electrolyte levels, particularly potassium and magnesium, are monitored closely to prevent electrolyte imbalances that could exacerbate arrhythmias. This scenario demands ongoing clinical reasoning and dynamic adjustments to the treatment plan to manage the complex interplay of heart failure, arrhythmias, and renal function effectively. As the team navigates these challenges, they prepare for the possibility of further interventions, including advanced hemodynamic monitoring, to ensure the patient's stability and recovery.

Section 4

As the medical team continues their diligent monitoring, approximately four hours after the initiation of diuretic therapy, they observe a notable change in the patient's status. His respiratory distress has slightly improved, with a respiratory rate now at 24 breaths per minute, and the auscultation of his lungs shows a reduction in bilateral crackles. However, despite these positive signs, the patient's blood pressure remains critically low at 88/54 mmHg. In response to these findings, the team decides to initiate a low-dose inotropic agent to enhance cardiac contractility and support blood pressure without significantly increasing myocardial oxygen demand.

Subsequent laboratory tests reveal an increase in serum potassium levels, now at 5.4 mEq/L, alongside a further rise in creatinine to 2.0 mg/dL. These results prompt the team to carefully evaluate the patient's renal function and electrolyte balance, adjusting the diuretic regimen to prevent hyperkalemia while considering the potential nephrotoxic effects of ongoing treatment. The team also decides to implement continuous cardiac monitoring to promptly detect any arrhythmias that may arise from these electrolyte disturbances.

The patient’s clinical trajectory highlights the intricate balance required in managing heart failure post-myocardial infarction, particularly with concurrent renal impairment. The team prepares for potential further interventions, including the consideration of renal replacement therapies if the patient's renal function continues to decline. With these new developments, the medical team remains vigilant, ready to adjust the treatment plan dynamically to ensure the patient's stability and recovery while maintaining a focus on preventing further complications.

Section 5

As the medical team continues to monitor the patient closely, they notice a subtle but concerning change in his status. Approximately two hours after the initiation of the inotropic agent, the patient begins to exhibit signs of increasing restlessness and confusion. A repeat neurological assessment reveals that he is now disoriented to time and place, which was not observed during the previous rounds. Concurrently, his heart rate has increased to 110 beats per minute, and he is exhibiting occasional premature ventricular contractions as detected on the continuous cardiac monitor. The team recognizes that these changes could be indicative of worsening cardiac output or electrolyte imbalances, potentially exacerbated by the inotropic therapy and altered renal function.

In response to these developments, the team orders a repeat set of laboratory tests, including a comprehensive metabolic panel and arterial blood gas analysis. The results reveal that the patient's serum potassium level has increased further to 5.8 mEq/L, and his creatinine has risen to 2.4 mg/dL, confirming a progression in his renal impairment. Additionally, the arterial blood gas shows a mild metabolic acidosis with a pH of 7.32, bicarbonate of 18 mEq/L, and a base excess of -5 mEq/L, indicating a possible accumulation of metabolic waste products due to decreased renal function.

Given these findings, the medical team deliberates on the next steps. They recognize the urgency to address the hyperkalemia to prevent further cardiac complications and the need to support the patient's renal function. Considering the risks and benefits, they decide to administer a calcium gluconate infusion to stabilize the cardiac membrane, initiate insulin and glucose therapy to temporarily shift potassium into the cells, and adjust the diuretic regimen to include a potassium-wasting diuretic. Additionally, they discuss the possibility of initiating renal replacement therapy should the patient's renal function continue to deteriorate. The team remains vigilant, understanding the delicate interplay between cardiac and renal systems, and prepared to adapt their management strategy as the patient's condition evolves.